deltatrials
Terminated PHASE1/PHASE2 INTERVENTIONAL NCT00048399

Stem Cell Transplantation for Patients With Graft Failure Following an Allogeneic Transplant, Using Identical or Near Identical Donors and Less Toxic Conditioning With CAMPATH 1H

Phase I/II Study of Allogeneic Stem Cell Transplantation For Patients With Graft Failure Following Allogeneic Transplantation Using MHC Identical or Near Identical Donors and Submyeloablative Conditioning With CAMPATH 1H (CAMGRAFT)

Sponsor: Baylor College of Medicine

Conditions Graft Failure
Interventions CAMPATH 1H FK506 Fludarabine Stem Cell Transplantation
Updated 7 times since 2017 Last updated: Jan 15, 2020 Started: Dec 31, 2000 Primary completion: Oct 31, 2003 Completion: Oct 31, 2003
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

accrual was slow

Other terminated trials from Baylor College of Medicine

See all terminations from Baylor College of Medicine

This PHASE1/PHASE2 trial investigates Graft Failure and is currently terminated or withdrawn. Baylor College of Medicine leads this study, which shows 7 recorded versions since 2000 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotTerminated~Jun 2018 – ~Feb 2020 · 20 months · monthly snapshotTerminated~Feb 2020 – ~Jan 2021 · 11 months · monthly snapshotTerminated~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshotTerminated~Oct 2021 – ~Jul 2024 · 33 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

7 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE1/PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  3. Oct 2021 — Jul 2024 [monthly]

    Terminated PHASE1_PHASE2

  4. Jan 2021 — Oct 2021 [monthly]

    Terminated PHASE1_PHASE2

  5. Feb 2020 — Jan 2021 [monthly]

    Terminated PHASE1_PHASE2

▶ Show 2 earlier versions

  1. Jun 2018 — Feb 2020 [monthly]

    Terminated PHASE1_PHASE2

  2. Jan 2017 — Jun 2018 [monthly]

    Terminated PHASE1_PHASE2

    First recorded

Dec 2000

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Baylor College of Medicine
  • The Methodist Hospital Research Institute
Data source: Baylor College of Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations